Webinars offer a variety of presentations from worldwide experts in the field of Biosimilars.

Biosimilars Summary Based on FDA Approval: Differences Between Biosimilars and Generics

Edward Li, PharmD, BCOPEdward Li, PharmD, MPH, BCOP
Associate Professor
University of New England College of Pharmacy
Portland, Maine

Recorded during “They're Here: Biosimilars in Practice, What Everyone Should Know” at the 57th ASH Annual Meeting* in Orlando, Florida on December 4, 2015. 
*This program is neither sponsored nor endorsed by ASH


Biosimilars: Payer and Formulary Considerations

Ross M. Miller, MD, MPH, FACPERoss M. Miller, MD, MPH, FACPE
Medical Advisor
California Department of Health Care Services
Los Angeles, California
 
 


Clinician and Payer Perspectives on the First Biosimilar Approved in the US

 

Gary H. Lyman, MD, MPHGary H. Lyman, MD, MPH
Co-Director
Hutchinson Institute for Cancer Outcomes Research
Professor of Medicine
University of Washington

 

Edmund J. Pezalla, MD, MPHEdmund J. Pezalla, MD, MPH
Vice President
Pharmaceutical Policy and Strategy
Aetna
Hartford, Connecticut


CME/CE Multimedia Modules

Welcome to Biologics and Biosimilars: Preparing for the Future!

This is a series of 8 interactive modules. Each module focuses on a different topic and answers questions clinicians commonly ask about biosimilars. It is highly recommended that you complete the entire curriculum.

Module 7
Module 5
Module 6
Module 3
Module 4
Module 2
Module 1
Module 8

Comprehensive Review of Biosimilars vs. Reference Biologics

jonathan kayJonathan Kay, MD
Director of Clinical Research
Rheumatology Division
UMASS Memorial Medical Center
Professor of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts
 


Current and Emerging Biosimilars Relevant to Hematology Practice

Gary H. Lyman, MD, MPHGary H. Lyman, MD, MPH
Hutchinson Institute for Cancer Outcomes Research
University of Washington
Seattle, Washington

Recorded during “They're Here: Biosimilars in Practice, What Everyone Should Know” at the 57th ASH Annual Meeting* in Orlando, Florida on December 4, 2015. 
*This program is neither sponsored nor endorsed by ASH


Global Perspective: Biosimilars Abroad

Pere Gascón, MD, PhD, FACPPere Gascón, MD, PhD, FACP
Hospital Clinic Professor in Medicine Department of Medical Oncology
University of Barcelona Medical School
Barcelona, Spain

Recorded during “They're Here: Biosimilars in Practice, What Everyone Should Know” at the 57th ASH Annual Meeting* in Orlando, Florida on December 4, 2015. 
*This program is neither sponsored nor endorsed by ASH


Interview: Expert Perspective on Biosimilars

Sanjiv S. Agarwala, MDSanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Health Network
Professor of Medicine
Temple University
Philadelphia, Pennsylvania


Review of Biosimilars: What You Need to Know

Andrew D. Zelenetz, MD, PhDAndrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
New York, New York

Recorded during “They're Here: Biosimilars in Practice, What Everyone Should Know” at the 57th ASH Annual Meeting* in Orlando, Florida on December 4, 2015. 
*This program is neither sponsored nor endorsed by ASH


The Fundamentals of Biosimilar Regulation and Development in the US

edward  liEdward Li, PharmD, MPH, BCOP
Associate Professor
University of New England College of Pharmacy
Portland, Maine
 


New & Noteworthy